Vp16
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1828 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 130 | 383 | 104 | 18 | 38 | 599 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | 79 | 188 | 77 | 4 | 22 | 328 |
| Leukemia | D007938 | — | C95 | 93 | 157 | 92 | 6 | 23 | 324 |
| Small cell lung carcinoma | D055752 | — | — | 68 | 163 | 66 | 3 | 20 | 284 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 60 | 141 | 33 | 5 | 8 | 211 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 32 | 75 | 41 | 9 | 14 | 152 |
| B-cell lymphoma | D016393 | — | — | 54 | 88 | 21 | 2 | 7 | 144 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 46 | 84 | 19 | 1 | 7 | 134 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 41 | 53 | 40 | 1 | 12 | 130 |
| Neoplasms | D009369 | — | C80 | 52 | 57 | 18 | 1 | 8 | 123 |
Show 25 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myeloid leukemia | D007951 | — | C92 | 39 | 52 | 37 | — | 13 | 125 |
| Carcinoma | D002277 | — | C80.0 | 15 | 52 | 16 | — | 2 | 75 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 19 | 33 | 21 | — | 5 | 74 |
| Recurrence | D012008 | — | — | 29 | 44 | 6 | — | 6 | 71 |
| Multiple myeloma | D009101 | — | C90.0 | 12 | 44 | 10 | — | 6 | 68 |
| Sarcoma | D012509 | — | — | 13 | 33 | 16 | — | 6 | 65 |
| Plasma cell neoplasms | D054219 | — | — | 9 | 39 | 9 | — | 4 | 59 |
| Myelodysplastic syndromes | D009190 | — | D46 | 22 | 24 | 13 | — | 3 | 54 |
| Central nervous system neoplasms | D016543 | — | — | 9 | 28 | 7 | — | 5 | 48 |
| Preleukemia | D011289 | — | — | 18 | 18 | 13 | — | 2 | 44 |
Show 115 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 7 | 15 | — | — | 5 | 24 |
| Plasmacytoma | D010954 | — | C90.3 | 6 | 15 | — | — | 2 | 23 |
| Hematologic neoplasms | D019337 | — | — | 7 | 7 | — | — | 3 | 16 |
| B-cell lymphoma marginal zone | D018442 | — | C88.4 | 5 | 7 | — | — | 3 | 12 |
| Aids-related lymphoma | D016483 | EFO_1001365 | — | 3 | 8 | — | — | 1 | 12 |
| Graft vs host disease | D006086 | — | D89.81 | 3 | 7 | — | — | 3 | 12 |
| Adult t-cell leukemia-lymphoma | D015459 | — | C91.5 | 3 | 6 | — | — | 2 | 10 |
| Lymphomatoid granulomatosis | D008230 | — | C83.8 | 4 | 4 | — | — | 3 | 9 |
| Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 3 | 6 | — | — | — | 9 |
| T-cell lymphoma cutaneous | D016410 | — | C84.A | 4 | 2 | — | — | 3 | 8 |
Show 131 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Large granular lymphocytic leukemia | D054066 | — | — | 2 | — | — | — | 2 | 4 |
| Neuroepithelial neoplasms | D018302 | — | — | 2 | — | — | — | — | 2 |
| Pharyngeal neoplasms | D010610 | — | C14.0 | 2 | — | — | — | — | 2 |
| Peritoneal neoplasms | D010534 | — | — | 2 | — | — | — | — | 2 |
| Melanoma | D008545 | — | — | 2 | — | — | — | — | 2 |
| Urethral neoplasms | D014523 | EFO_0003846 | — | 1 | — | — | — | — | 1 |
| Pancreatic ductal carcinoma | D021441 | — | — | 1 | — | — | — | — | 1 |
| Esophageal squamous cell carcinoma | D000077277 | — | — | 1 | — | — | — | — | 1 |
| Deltaretrovirus infections | D006800 | EFO_1001303 | — | 1 | — | — | — | — | 1 |
| Htlv-i infections | D015490 | EFO_0007316 | — | 1 | — | — | — | — | 1 |
Show 19 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chediak-higashi syndrome | D002609 | Orphanet_167 | D72.0 | — | — | — | — | 2 | 2 |
| Paroxysmal hemoglobinuria | D006457 | Orphanet_447 | D59.12 | — | — | — | — | 1 | 1 |
| Hemoglobinuria | D006456 | — | R82.3 | — | — | — | — | 1 | 1 |
| Multiple primary neoplasms | D009378 | — | — | — | — | — | — | 1 | 1 |
| Ataxia | D001259 | — | R27.0 | — | — | — | — | 1 | 1 |
| Ataxia telangiectasia | D001260 | Orphanet_100 | G11.3 | — | — | — | — | 1 | 1 |
| Telangiectasis | D013684 | — | — | — | — | — | — | 1 | 1 |
| Cerebellar ataxia | D002524 | HP_0001251 | — | — | — | — | — | 1 | 1 |
| Peripheral blood stem cell transplantation | D036102 | — | — | — | — | — | — | 1 | 1 |
| Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | — | — | 1 | 1 |
Show 15 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use